Published studies suggest continuous manufacturing can lower the cost of oral solid dose production: one widely cited case study estimated overall savings of 9% to 40% versus batch, and a later NPV simulation found CM could make US OSD manufacturing more attractive than foreign batch production. For generics, where margins are thin, the case depends on volume, product stability over many years, and capability to develop and run PAT-based control. CM tends to pay for high-volume, long-life products more than for small, frequently changing portfolios.
What the studies say
- A 2011 case study of integrated continuous vs batch manufacturing estimated overall cost savings of 9% to 40% depending on scenario.
- A stochastic NPV study of new OSD facilities concluded CM could make US manufacturing more economically attractive than foreign batch manufacturing.
- Generics makers are attracted by potential reductions in cost of goods, footprint, staffing and materials, according to trade press.
Where savings come from
| Area | Effect |
|---|---|
| Footprint and building | Smaller equipment train and fewer intermediate holds |
| Labour | Fewer manual transfers and handling steps |
| Scale-up | Run longer rather than build bigger equipment |
| Quality | Real-time control, fewer failed batches |
| Inventory | Shorter cycle times and less work in progress |
Decision framework for generics
- Volume: is there enough sustained demand for near-continuous running?
- Portfolio: how many products and changeovers?
- Regulatory: cost and time of filing CM for existing products (post-approval changes).
- Capability: PAT, modelling, automation and data skills.
- Comparison: an optimised batch line may close much of the gap; see TCO method.
Technology overview: continuous manufacturing for tablets.
Companies listed in the Hello Pharma supplier directory
The Hello Pharma supplier directory lists 77 companies relevant to this guide, grouped below by machine type or category. Each name links to the company's directory entry, with a description, technologies, location and website. Companies confirmed against their websites or public listings appear first in each group.
Inclusion is not an endorsement or ranking. Many categories are inferred from company names and segments, so confirm capabilities, approvals and service reach directly with each supplier. Search all 1,232 companies.
Granulation (48)
ACG Worldwide Solid Dosage Consumables and Machinery; Anish Pharma Equip Pvt. Ltd; Bectochem Consultant & Engineers Pvt. Ltd.; Bowman & Archer Pharma Machines (India) Pvt.Ltd; Cadmach Machinery Co. Pvt Ltd; Fabtech Technologies International Ltd.; Gansons Limited; Indo German Pharma Engineers; Parle Global Technologies Pvt. Ltd.; Prism Pharma Machinery; Saan Engineers Pvt Ltd; Solace Engineers (Mktg) Pvt. Ltd.; SSPM Systems & Engineers; Sunsai Pharma Equipments Pvt. Ltd.; Tapasya Engineering Works Pvt Ltd; Allegro Pharmachem Equipments; Ambica Engineering Works; Astro Mech; BEW Engineering Pvt. Ltd.; Bombay Pharma Equipments Pvt Ltd; Bright Pharma Engineering Private Limited; Brilliant Process Machinery Pvt. Ltd.; Brinda Pharma Technologies Pvt Ltd.; CEMACH; Dumra Machines; Gem Pharma Machineries; Glatt Group; Grovers International; Helios Concrew Machines; HLE Engineers Pvt. Ltd.; Imperial Pharmachines Pvt Ltd; Indo Rama Engineers; Laxmi Pharma Machines; LEISTUNG ENGINEERING PVT LTD; Mack Pharmatech Pvt. Ltd.; Mecwell Pharma Machinery Pvt. Ltd.; Omega Pharma Machinery; Pankaj Industries; Pharma Mech Machineries; Promp+tech Pharma Equipments (India) Pvt Ltd and 8 more.
Open the full entries: Oral solid dosage equipment list filtered to granulation · Engineering and validation services list filtered to granulation · Sterile, injectable and liquid equipment list filtered to granulation
Automation and controls (29)
Accupack Engineering Pvt Ltd; Adam Fabriwerk; A.S. Automations; Appidi Technologies Pvt. Ltd.; Avcon Controls Pvt. Ltd.; B&R Industrial Automation Pvt. Ltd.; B.D. Industries; Crystal Automation Pvt. Ltd; Electronics Devices Worldwide Pvt Ltd; Elektrocraft (India) Pvt. Ltd.; Hilda Automation; Inline Technologies; Jay Instruments & Systems Pvt Ltd; Kesar Control Systems; MICROCON; Millenia Technologies; Mitsubishi Electric India Pvt Ltd.; Ngen Controls System; Nord Drivesystems Pvt Ltd; P.M Electro Auto Pvt. Ltd; PRETECH Automation Pvt. Ltd.; Protech Technologies Pvt. Ltd.; Radix Electrosystems Pvt. Ltd.; Saksham Technologies Pvt. Ltd.; Shubham Automation Pvt. Ltd.; Sierra Instrumentation & Controls; Staubli Tec Systems India Pvt Ltd; Sunjay Technologies Pvt Ltd; Toshniwal Instrument Mfg.Pvt.Ltd.
Open the full entries: Automation, inspection and serialization list filtered to automation and controls · Packaging machinery list filtered to automation and controls · Components and spares list filtered to automation and controls · Sterile, injectable and liquid equipment list filtered to automation and controls
Frequently asked questions
Does continuous manufacturing save money for generics?
It can, for high-volume, long-life products. Studies report savings from 9% to 40% in some scenarios, but results vary.
What are the main barriers?
Capital cost, PAT and data skills, regulatory filing effort, and fit with multi-product portfolios.
Should I convert existing batch products?
Only where volume and remaining product life justify the development and regulatory costs.
Is an optimised batch line a better option?
Sometimes. Compare both on total cost of ownership with realistic assumptions.
Related guides
Sources
- Economic analysis of integrated continuous and batch pharmaceutical manufacturing (Schaber et al., 2011), University of Edinburgh repository
- Economics of continuous vs batch OSD manufacturing (Rossi), PubMed Central
- Continuous versus batch: weighing the choices, Pharma Manufacturing
- 21st century OSDs: times they are changin', Pharmaceutical Technology
This guide is general information to support decisions and is not engineering, validation or regulatory advice for a specific project.
